Preferred Name |
morazone |
|
Synonyms |
4-((3-methyl-2-phenylmorpholino)methyl)antipyrine 1,2-dihydro-1,5-dimethyl-4-((3-methyl-2-phenyl-4-morpholinyl)methyl)-2-phenyl-3H-pyrazol-3-one tarugan 1-phenyl-2,3-dimethyl-4-(2'-phenyl-3'-methylmorpholinomethyl)pyrazolone morazone monohydrochloride |
|
ID |
http://purl.bioontology.org/ontology/MESH/C009385 |
|
altLabel |
4-((3-methyl-2-phenylmorpholino)methyl)antipyrine 1,2-dihydro-1,5-dimethyl-4-((3-methyl-2-phenyl-4-morpholinyl)methyl)-2-phenyl-3H-pyrazol-3-one tarugan 1-phenyl-2,3-dimethyl-4-(2'-phenyl-3'-methylmorpholinomethyl)pyrazolone morazone monohydrochloride |
|
cui |
C0066795 C0952035 |
|
Has mapping qualifier | ||
HM |
D000983/Q000031 |
|
Inverse of RB |
50321-35-2 870Q5BL2FN |
|
Mapped to | ||
MDA |
19740101 |
|
MeSH Frequency |
6 |
|
MMR |
20121105 |
|
notation |
C009385 |
|
PI |
*MORPHOLINES (74-82) *PYRAZOLES (74-80) |
|
prefLabel |
morazone |
|
RR |
6536-18-1 (morazone) 50321-35-2 (mono-HCl) |
|
SC |
1 |
|
Scope Statement |
RN given refers to parent cpd; structure |
|
SRC |
Arch Toxicol 35(3):213;1976 Beitr Gerichtl Med 34:117;1976 J Chromatogr 84(2):419;1973 |
|
TERMUI |
T084033 T084034 T084031 T084032 T340747 |
|
TH |
FDA SRS (2013) USAN (1974) INN (19XX) NLM (1974) |
|
tui |
T109 T121 |